Modus Therapeutics (Sweden) Today
| MODTX Stock | 0.40 0.03 8.11% |
PerformanceWeakest
| Odds Of DistressHigh
|
Modus Therapeutics is selling for under 0.4 as of the 16th of November 2025; that is 8.11 percent increase since the beginning of the trading day. The stock's lowest day price was 0.34. Modus Therapeutics has more than 65 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 18th of August 2025 and ending today, the 16th of November 2025. Click here to learn more.
Moving against Modus Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Modus Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Modus Therapeutics' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Modus Therapeutics or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Modus Therapeutics Holding (MODTX) is traded on Stockholm Exchange in Sweden and employs 2 people. The company currently falls under 'Micro-Cap' category with a current market capitalization of 74.95 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Modus Therapeutics's market, we take the total number of its shares issued and multiply it by Modus Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Modus Therapeutics operates under Healthcare sector and is part of Biotechnology industry. The entity has 16.1 M outstanding shares.
Modus Therapeutics generates negative cash flow from operations
Check Modus Therapeutics Probability Of Bankruptcy
Ownership AllocationModus Therapeutics maintains a total of 16.1 Million outstanding shares. Modus Therapeutics Holding secures majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 79.18 % of Modus Therapeutics Holding outstanding shares that are owned by insiders conveys that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Modus Ownership Details
Modus Therapeutics Risk Profiles
Although Modus Therapeutics' alpha and beta are two of the key measurements used to evaluate Modus Therapeutics' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 6.59 | |||
| Standard Deviation | 10.44 | |||
| Variance | 109.0 | |||
| Risk Adjusted Performance | (0.08) |
Modus Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Modus Therapeutics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Piotroski F Score Now
Piotroski F ScoreGet Piotroski F Score based on the binary analysis strategy of nine different fundamentals |
| All Next | Launch Module |
Additional Tools for Modus Stock Analysis
When running Modus Therapeutics' price analysis, check to measure Modus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Modus Therapeutics is operating at the current time. Most of Modus Therapeutics' value examination focuses on studying past and present price action to predict the probability of Modus Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Modus Therapeutics' price. Additionally, you may evaluate how the addition of Modus Therapeutics to your portfolios can decrease your overall portfolio volatility.